Singapore markets closed

Aridis Pharmaceuticals, Inc. (ARDS)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
0.0700-0.0024 (-3.31%)
At close: 03:18PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
4,876
18,098
8,232
20,897
Total cash
4,876
18,098
8,232
20,897
Net receivables
1,000
0
-
0
Total current assets
11,626
24,390
12,755
25,837
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
4,190
2,942
2,413
1,829
Accumulated depreciation
-2,043
-1,585
-1,155
-823
Net property, plant and equipment
2,147
1,357
1,258
1,006
Equity and other investments
-
-
-
9
Intangible assets
17
22
27
32
Other long-term assets
827
931
987
557
Total non-current assets
3,069
2,406
2,362
2,130
Total assets
14,695
26,796
15,117
27,967
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
4,300
696
439
-
Accounts payable
2,308
5,240
1,886
1,755
Accrued liabilities
9,564
6,464
1,330
2,974
Deferred revenues
20,173
20,838
18,748
14,602
Other current liabilities
15
110
37
-
Total current liabilities
36,898
33,348
22,440
19,331
Non-current liabilities
Long-term debt
-
5,282
276
-
Deferred revenues
737
913
854
5,000
Other long-term liabilities
-
363
228
-
Total non-current liabilities
2,029
6,558
1,358
5,000
Total liabilities
38,927
39,906
23,798
24,331
Stockholders' equity
Common stock
3
2
1
1
Retained earnings
-195,666
-165,295
-123,102
-100,769
Accumulated other comprehensive income
5,051
0
-
-
Total stockholders' equity
-24,232
-13,110
-8,681
3,636
Total liabilities and stockholders' equity
14,695
26,796
15,117
27,967